Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Diabetes raises risk of prostate cancer mortality in obese men
Key clinical point: Diabetes was associated with prostate cancer-specific mortality in obese men, but not in nonobese men.
Major finding: Among obese men, diabetes was significantly associated with increased risk of prostate cancer-specific mortality in a multivariate analysis (adjusted hazard ratio 3.06).
Study details: The data come from a cohort of 4,688 men who underwent radical prostatectomy between 1988 and 2017.
Disclosures: The study was supported by the National Institutes of Health. The researchers had no financial conflicts to disclose.
Source: Kelkar S et al. JNCI Cancer Spectr. 2021 Mar 9. doi: 10.1093/jncics/pkab023.